Assignee
DEBREGEAS ET ASSOCIES PHARMA
FR·3 granted patents·2 pending applications·0 citations·filing 2013–2018
Top patents by PatentIndex Score
5 records- 0143US10441585B2Formulations containing nalbuphine and uses thereofDEBREGEAS ET ASSOCIES PHARMA·Filed 2016·Granted Oct 15, 2019·0 cites·10 claims
- 0242US9782367B2Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereofDEBREGEAS ET ASSOCIES PHARMA·Filed 2013·Granted Oct 10, 2017·0 cites·10 claims
- 0342US2018193277A1Gamma-hydroxybutyric acid granulesDEBREGEAS ET ASSOCIES PHARMA·Filed 2018·Application pending·0 cites
- 0440US2015073055A1Use of modafinil in the treatment of cocaine addictsDEBREGEAS ET ASSOCIES PHARMA·Filed 2013·Application pending·0 cites
- 0530US11690816B2Unit doses for immediate release of GHB or of one of the therapeutically acceptable salts thereof, administered orally, and the use thereof to maintain alcohol abstinenceDEBREGEAS ET ASSOCIES PHARMA·Filed 2017·Granted Jul 4, 2023·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when DEBREGEAS ET ASSOCIES PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →